[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_918 

# __Development of graphene-based antiviral coatings__

## Category to which it belongs

* [Implement comprehensive strategies to control virus transmission, improve surveillance, develop antiviral coatings, and enhance infection control measures.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_302.md)

## Closest similar item

* [Use of nanomaterials and graphene-based coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_919.md)
* [Application of antiviral surface coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_921.md)
* [Antiviral surface coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_917.md)
* [Development of robust antiviral coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_920.md)
* [Disinfection of surfaces and development of antiviral coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1579.md)
* [Regular monitoring of coated surfaces for changes in viral viability and development of alternative coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1633.md)
* [Application of antimicrobial coatings](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_574.md)
* [Develop techniques to improve solubility and processing of graphene](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1581.md)
* [Research and development of antiviral technologies that are effective against a wider range of viruses.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2038.md)
* [Development of more advanced self-disinfecting surface technologies with enhanced antiviral action.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2037.md)

## Benefits linked to a risk

* [Enhanced treatment options](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_918.md)

## Risks possibly mitigated by this Mitigation

* [Limited availability and effectiveness of antiviral treatments](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_654.md)

